[1]
2023. Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. Biomolecules and Biomedicine. 23, 2 (Mar. 2023), 351. DOI:https://doi.org/10.17305/bjbms.2022.8354.